Central Banks
Markets
Strategy Builder
COT Data
Advanced News
Research
New
Earnings Calendar
Economic Calendar
Toggle theme
Log In
Sign Up
We use cookies
Privacy Policy
Accept
Decline
RARE Earnings — Ultragenyx Pharmaceutical Inc. | Dates and Estimates | EL7.AI
RARE Earnings
Ultragenyx Pharmaceutical Inc.
Next report
2026-11-03
AMC
Q3 FY2026
Expected date
EPS consensus
-0.63
-1.43 – 0.27
5 analysts
Revenue consensus
$0.18B
Beat streak
1
Recent quarters
Quarter
Estimate
Actual
Surprise
Q2 FY2026
-1.22
-0.90
+26.2%
Q1 FY2026
-1.49
-1.84
-23.7%
Open the earnings calendar
View stock page
